Why is Thyrocare Tech. falling/rising?

As of 13-Jun, Thyrocare Technologies Ltd is experiencing a price increase, currently at 1,023.40, reflecting a rise of 38.55 or 3.91%. The stock has shown strong performance today, outperforming its sector by 3.38% and trading above all key moving averages. It is also close to its 52-week high, being only 4.79% away from Rs 1,072.45. Over the past week, the stock has gained 7.38%, significantly outpacing the Sensex, which has declined by 1.30%. Despite a recent drop in investor participation, with delivery volume falling by 39.34% against the 5-day average, the company has demonstrated high management efficiency, a low debt-to-equity ratio, and impressive operating profit growth, contributing to its positive momentum.
In the broader market context, Thyrocare's short-term performance has been notably strong compared to the benchmark, with a 1-week return of 7.38% against the Sensex's decline. However, there are concerns regarding long-term growth, as the company's operating profit has decreased at an annual rate of -0.80% over the past five years. Additionally, the stock is trading at a premium valuation compared to its peers, which may pose risks in a falling market, especially given that 100% of promoter shares are pledged. Despite these risks, the stock's recent performance and positive financial results have contributed to its upward movement.